1Neurophysiopathology Service, S. Luca Hospital, Vallo della Lucania, ASL SA-3, Italy
2Ophthalmology Division, S. Luca Hospital, Vallo della Lucania, ASL SA-3, Italy
3Department of Neurological Science, II University of Naples, Italy
4Department of Pharmacy, University of Salerno, Italy
*Correspondemce to: Vincenzo Pizza, Neurophysiopathology Service, S. Luca Hospital, Vallo della Lucania, ASL SA-3, Italy
Online published on 14 November, 2013.
Recent evidences indicate that migraine may be involved as a risk factor for cerebral infarction in young women, thus indicating an undisputable connection between migraine and cerebral ischaemia [1–3]. Although the nature of this connection remains essentially unknown, several studies have been devoted to the detection of markers of a prothrombotic tendency in migrainous subjects [1–4]. In the present study, we have evaluated the possible relationship between migraine and prothrombotic genetic risk factors. MN and MM, 52 year old monozygotic male twins, and MA 27-year old daughter of MM are suffering from migraine with aura (International Headache Society, 2004 criteria) since 15 years of age and have a familial history of cardio-cerebral vascular disease. MN is affected with angina pectoris and MM with myocardial infarction and transient ischemic accident. Data of laboratory examinations for screening of the prothrombotic state revelead: MN: Factor XI:c 128.2% (range 70–120), Factor XII:c 150.4% (range 70–120), Activated Protein C-resistance (APT) 0.6 (range >0.7), Plasma Homocysteine 29 mmol/L (range 5–15), MTHFR gene (TT/CC). MM: Factor XII:c 138.6% (range 70–120), APC-resistance 0.6 (range >0.7), Plasma Homocysteine 40.2 mmol/L (range 5–15), MTHFR gene (TT/CC). MA: Factor XII:c 132.2% (range 70–120), APC-resistance 0.5 (range >0.7), Plasma Homocysteine 30.6 mmol/L (range 5–15), MTHFR gene (TT/CC), PAI-1 4G/5G. Although there are no data in literature on prothrombotic genetic risk factors in patients suffering from migraine, our data seem to demonstrate a strict association between migraine with aura history, cardio-cerebral vascular disease and prothrombotic genetic risk factors, thus suggesting that haemostatic risk factors for arterial thrombosis could play an important role in the clinical study of these patients.
Migraine, cerebral ischaemia, prothrombotic genetic risk factors